AAAAAA
Results:
1-14
|
Results: 14
Authors:
Schiller, G
Wong, S
Lowe, T
Snead, G
Paquette, R
Sawyers, C
Wolin, M
Kunkel, L
Ting, L
Li, G
Territo, M
Citation: G. Schiller et al., Transplantation of IL-2-mobilized autologous peripheral blood progenitor cells for adults with acute myelogenous leukemia in first remission, LEUKEMIA, 15(5), 2001, pp. 757-763
Authors:
Esses, D
Gallagher, EJ
Iannaccone, R
Bijur, P
Srinivas, VS
Rose, H
Kunkel, L
Sokolof, J
Citation: D. Esses et al., Six-hour versus 12-hour protocols for AMI: CK-MB in conjunction with myoglobin, AM J EMER M, 19(3), 2001, pp. 182-186
Authors:
Byrd, JC
Murphy, T
Howard, RS
Lucas, MS
Goodrich, A
Park, K
Pearson, M
Waselenko, JK
Ling, G
Grever, MR
Grillo-Lopez, AJ
Rosenberg, J
Kunkel, L
Flinn, IW
Citation: Jc. Byrd et al., Rituximab using a thrice weekly dosing schedule in B-Cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity, J CL ONCOL, 19(8), 2001, pp. 2153-2164
Authors:
Wagner, TH
Hibbard, JH
Greenlick, MR
Kunkel, L
Citation: Th. Wagner et al., Does providing consumer health information affect self-reported medical utilization? Evidence from the Healthwise Communities Project, MED CARE, 39(8), 2001, pp. 836-847
Authors:
Atkins, MB
Kunkel, L
Sznol, M
Rosenberg, SA
Citation: Mb. Atkins et al., High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: Long-term survival update, CA J SCI AM, 6, 2000, pp. S11-S14
Authors:
Grillo-Lopez, AJ
Kunkel, L
Citation: Aj. Grillo-lopez et L. Kunkel, Correspondence re: T. Davis et al, therapy of B-cell lymphoma with anti-CD20 antibodies can result in loss of CD20 antigen expression. Clin. Cancer Res., 5 : 611-615, 1999., CLIN CANC R, 6(1), 2000, pp. 317-318
Authors:
Kunkel, L
Wong, A
Maneatis, T
Nickas, J
Brown, T
Grillo-Lopez, A
Benyunes, M
Grobman, B
Dillman, RO
Citation: L. Kunkel et al., Optimizing the use of rituximab for treatment of B-cell non-Hodgkin's lymphoma: A benefit-risk update, SEMIN ONCOL, 27(6), 2000, pp. 53-61
Authors:
Saleh, MN
Gutheil, J
Moore, M
Bunch, PW
Butler, J
Kunkel, L
Grillo-Lopez, AJ
LoBuglio, AF
Citation: Mn. Saleh et al., A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia, SEMIN ONCOL, 27(6), 2000, pp. 99-103
Authors:
Perls, T
Terry, DF
Silver, M
Shea, M
Bowen, J
Joyce, E
Ridge, SB
Fretts, R
Daly, M
Brewster, S
Puca, A
Kunkel, L
Citation: T. Perls et al., Centenarians and the genetics of longevity, RES PRO CEL, 29, 2000, pp. 1-20
Authors:
Perls, T
Shea-Drinkwater, M
Bowen-Flynn, J
Ridge, SB
Kang, S
Joyce, E
Daly, M
Brewster, SJ
Kunkel, L
Puca, AA
Citation: T. Perls et al., Exceptional familial clustering for extreme longevity in humans, J AM GER SO, 48(11), 2000, pp. 1483-1485
Authors:
Kunkel, L
Citation: L. Kunkel, Caveolin-3 deficiency as a cause of limb-girdle muscular dystrophy, J CHILD NEU, 14(1), 1999, pp. 33-34
Authors:
Atkins, MB
Lotze, MT
Dutcher, JP
Fisher, RI
Weiss, G
Margolin, K
Abrams, J
Sznol, M
Parkinson, D
Hawkins, M
Paradise, C
Kunkel, L
Rosenberg, SA
Citation: Mb. Atkins et al., High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993, J CL ONCOL, 17(7), 1999, pp. 2105-2116
Authors:
Hibbard, JH
Greenlick, M
Jimison, H
Kunkel, L
Tusler, M
Citation: Jh. Hibbard et al., Prevalence and predictors of the use of self-care resources, EVAL HEALTH, 22(1), 1999, pp. 107-122
Authors:
Emmanouilides, C
Rosen, P
Rasti, S
Territo, B
Kunkel, L
Citation: C. Emmanouilides et al., Treatment of indolent lymphoma with fludarabine/mitoxantrone combination: A phase II trial, HEMATOL ONC, 16(3), 1998, pp. 107-116
Risultati:
1-14
|